Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Blog
    • Protocol for...

    Protocol for ultrasound scan to detect Multiple Pregnancy: Dr Vidhya Moorthy

    Written by Deepanjana Sarkar Published On 2019-04-02T19:03:32+05:30  |  Updated On 2 April 2019 7:03 PM IST
    Protocol for ultrasound scan to detect Multiple Pregnancy: Dr Vidhya Moorthy

    An update to care and management of multiple pregnancy- Dr Vidhya Moorthy


    The incidence of multiple pregnancy is 9 per 1000 live births in India. This is increasing in the last few decades with increasing rates of assisted conceptions with more than one embryo transfer. Hence it is important for clinicians to remain up to date with the management of these high-risk pregnancies. Ultrasound scan plays a vital role in the diagnosis of the multiple pregnancy, to determine the chorionicity and amnionicity, to formulate a plan of care for the rest of the pregnancy based on that.


    Indizygotic twins each fetus has its own placenta and amniotic sac. In monozygotic pregnancies, there may be a sharing of the same placenta (monochorionic), amniotic sac (monoamniotic) or even fetal organs (conjoined). One-third of monozygotic twins are dichorionic (DC) and two-thirds are monochorionic (MC). Therefore, all MC twins are monozygotic and 6 out of 7 DC twins are dizygotic. In case of monochorionic twin pregnancy more frequent scans to assess for selective fetal growth restriction and twin to twin transfusion syndrome is essential. Hence evidence-based protocols for ultrasound scan in multiple pregnancy is mandatory in every high-risk pregnancy unit, especially the fertility centres.


    Viability scan:




    • The aim of the ultrasound scan is to confirm intra-uterine pregnancy, demonstrate the fetal heartbeat and to identify the number of fetuses. The inter-fetal membrane is very thin to visualize at this early gestation and chorionicity and amnionicity is best determined at 11-14 weeks.


    Pregnancy dating:




    • Spontaneous conception: use the crown-rump length of the longest fetus at 11-13 weeks.

    • IVF conception: use the embryonic age from fertilization.


    Determination of chorionicity:




    • The best way to determine chorionicity by ultrasound at 11-13 weeks’ gestation is to examine the junction between the inter-fetal membrane and the placenta. In DC pregnancies there is a triangular placental tissue projection (λ sign) into the base of the In-MC pregnancies there is no placental tissue projection into the base of the membrane (T sign).

    • With advancing gestation, there is regression of the chorion laeve and the ‘lambda’ sign becomes progressively more difficult to identify. Thus by 20 weeks only 85% of DC pregnancies demonstrate the λ sign.


    Identify the fetus:




    • It is important to identify the fetuses and name them as A, B, C and to clearly document it. The fetus closer to the cervix is named usually as A and the position of the other fetus/ fetuses should be named in relation to the fetus A (upper/ lower, right/ left) This is important for invasive procedures and selective fetal reduction. The varying position of the placenta and the gender can be helpful to identify the fetus in the later gestation.


    First trimester aneuploidy screening:




    • Women who wish to have aneuploidy screening should be offered nuchal translucency measurements in conjunction with first trimester serum markers (combined screeningtest) at 11 weeks to 14 weeks of gestation (crown–rump length 45–84 mm).

    • In Dichorionic twins, the risk is calculated for each fetus and the NT measurements of each fetus is used. In monochorionic pregnancy, the risk is calculated for the pregnancy and the average of the two NT measurement has to be used.


    Measurements:




    • In each scan assess fetal growth (head circumference, abdominal circumference, femur length), amniotic fluid (deepest vertical pool), pulsatility index by Doppler (umbilical artery, middle cerebral artery and ductus venous) and in monochorionic twins’ middle cerebral artery peak systolic velocity to detect possible twin anemia–polycythemia sequence (TAPS).

    • At 20 weeks measure cervical length. If <25 mm, vaginal progesterone administration is recommended as per local protocol. If there is progressive cervical shortening then give prophylactic steroids for fetal lung maturity. There is no good evidence to support bed rest or cervical cerclage.


    Dichorionic twins:




    • Scans at 12, 20 weeks and then every 4 weeks until delivery.

    • If there is discordance in fetal size of >15%, discordance in amniotic fluid or any abnormal Doppler then review every 1 week.

    • If there is no complication, consider delivery at 37 weeks.


    Monochorionic diamniotic twins:




    • Scans at 12 and 16 weeks and then every 2 weeks until delivery.

    • If there is discordance in fetal size of >15%, discordance in amniotic fluid or any abnormal Doppler then review every 1 week.

    • If there is no complication, consider delivery at 36 weeks.


    Monochorionic monoamniotic twins:




    • Scans at 12 and 16 weeks and then every 2 weeks until delivery.

    • If there is discordance in fetal size of >15% or any abnormal Dopplers then review every 1 week.

    • If there is no complication, delivery by caesarean section at 32 weeks.


    Trichorionic triplets:




    • 12 weeks: counsel concerning options of expectant management or embryo reduction.

    • Scans at 12, 20, 24, 28 and 32 weeks.

    • If there is discordance in fetal size of >15%, discordance in amniotic fluid or any abnormal Doppler then review every 1 week.

    • If there is no complication, consider delivery by caesarean section at 34 weeks.


    Monochorionic or dichorionic triplets:




    • 12 weeks: counsel concerning options of expectant management or embryo reduction.

    • Scans at 12 and 16 weeks and then every 2 weeks until delivery.

    • If there is discordance in fetal size of >15%, discordance in amniotic fluid or any

    • Abnormal Doppler then review every 1 week.

    • If there is no complication, delivery by caesarean section at 32-34 week


    Dr Vidhya Moorthy, MRCOG (UK), Diploma in Fetal Medicine (FMF, London) Consultant Fetal Medicine and Obstetrics, Birthright by Rainbow Children’s Hospital, Chennai.
    Birthright by Rainbow Children’s HospitalChennaiConsultant Fetal MedicinedoctorDr MoorthyDr Vidhya Moorthyembryo transferfetal organshigh-risk pregnanciesIndizygotic twinsIVF conceptionlive birthsmiddle cerebral arterymultiple pregnancyobstetricsObstetrics Doctorprotocolsystolic velocityTrichorionic tripletstwin anemia–polycythemia sequencetwin transfusion syndromeUltrasound scan

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Deepanjana Sarkar
    Deepanjana Sarkar
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok